CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-22 | GIVEN DOUGLAS B Director | Sale | −3,000 | $18.05 | $54K | 175,130 |
| 2019-02-19 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +8,000 | $5.20 | $42K | 313,607 |
| 2019-02-19 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −8,000 | $18.00 | $144K | 305,607 |
| 2019-02-19 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −8,000 | 235,000 | ||
| 2019-02-19 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +42,500 | $2.01 | $85K | 687,106 |
| 2019-02-19 | GIVEN BRUCE D Chief Operating Officer | Sale | −42,500 | $17.98 | $764K | 644,606 |
| 2019-02-19 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −42,500 | 435,000 | ||
| 2019-02-15 | GIVEN BRUCE D Chief Operating Officer | Sale | −26,250 | $17.67 | $464K | 644,606 |
| 2019-02-12 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +42,500 | $2.01 | $85K | 713,356 |
| 2019-02-12 | GIVEN BRUCE D Chief Operating Officer | Sale | −42,500 | $17.06 | $725K | 670,856 |
| 2019-02-12 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −42,500 | 477,500 | ||
| 2019-02-11 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +11,667 | $2.62 | $31K | 825,023 |
| 2019-02-11 | GIVEN BRUCE D Chief Operating Officer | Sale | −97,167 | $15.66 | $1.5M | 727,856 |
| 2019-02-11 | GIVEN BRUCE D Chief Operating Officer | Sale | −57,000 | $16.48 | $939K | 670,856 |
| 2019-02-11 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −11,667 | 520,000 | ||
| 2019-02-08 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +11,667 | $2.62 | $31K | 859,523 |
| 2019-02-08 | GIVEN BRUCE D Chief Operating Officer | Sale | −46,167 | $15.34 | $708K | 813,356 |
| 2019-02-08 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −11,667 | 531,667 | ||
| 2019-02-05 | GIVEN BRUCE D Chief Operating Officer | Sale | −22,500 | $14.48 | $326K | 847,856 |
| 2019-02-01 | GIVEN BRUCE D Chief Operating Officer | Sale | −28,500 | $13.85 | $395K | 870,356 |
Page 31 of 38 · 752 trades